GLP3-R

Price range: $99 through $199

Retatrutide is a synthetic peptide studied as a triple-agonist of GLP-1, GIP, and glucagon receptors. Laboratory models evaluate its multi-receptor pharmacology, GPCR signaling dynamics, and downstream molecular pathway interactions. All applications are limited to non-clinical research use.

  • $99 / month — Save 10%

Description

What It Is Retatrutide is a synthetic peptide studied as a multi-receptor agonist targeting the glucagon-like peptide-1 receptor (GLP-1R), glucose-dependent insulinotropic polypeptide receptor (GIPR), and glucagon receptor (GCGR) in experimental systems.
What It’s Derived From Retatrutide is engineered from a modified peptide backbone incorporating structural elements that enable receptor engagement across GLP-1R, GIPR, and GCGR. The molecule includes a lipid side-chain modification designed to enhance molecular stability and prolong activity in controlled laboratory models.
What Research Focuses On Experimental investigations evaluate retatrutide in in vitro and in vivo preclinical systems examining multi-receptor incretin pharmacology, GPCR-mediated signaling dynamics, receptor co-activation mechanisms, intracellular cAMP-associated pathways, and downstream metabolic signaling biomarkers under defined laboratory conditions.

Additional information

Weight 0.0125 lbs
Dimensions 0.625 × 0.625 × 1.5 in
Dosage

10mg, 20mg, 30mg

Reviews

There are no reviews yet.

Be the first to review “GLP3-R”

Your email address will not be published. Required fields are marked *